Genmab A/S
GMAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434265
No open-market purchases or sales by Genmab A/S insiders were filed in the last 90 days; 291 institutions reported holding it in 13F filings for Q2 2026, worth $2.81B in total; no superinvestor holds it.
Other share classesGNMSF
13F holders, Q2 2021
Institutional positions in Genmab A/S as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 213
- +3 vs. Q1 2021
- Shares held
- 46.2M
- +8.51M (+22.6%) vs. Q1 2021
- Total value
- $1.89B
- +$659.5M (+53.6%) vs. Q1 2021
- New holders
- 43
- 84 more added
- Sold out
- 40
- 55 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GMAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 291 | $2.81B |
| Q1 2026 | 275 | $2.23B |
| Q4 2025 | 293 | $2.26B |
| Q3 2025 | 253 | $1.89B |
| Q2 2025 | 218 | $1.32B |
| Q1 2025 | 220 | $1.27B |
| Q4 2024 | 230 | $1.27B |
| Q3 2024 | 224 | $1.27B |
| Q2 2024 | 220 | $1.23B |
| Q1 2024 | 227 | $1.43B |
| Q4 2023 | 226 | $1.48B |
| Q3 2023 | 234 | $1.67B |
| Q2 2023 | 214 | $1.59B |
| Q1 2023 | 217 | $1.62B |
| Q4 2022 | 238 | $1.94B |
| Q3 2022 | 194 | $1.43B |
| Q2 2022 | 181 | $1.15B |
| Q1 2022 | 204 | $1.41B |
| Q4 2021 | 212 | $1.58B |
| Q3 2021 | 213 | $1.89B |
| Q2 2021 | 213 | $1.89B |
| Q1 2021 | 211 | $1.37B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Genmab A/S; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Creative Financial Designs Inc | 52 | $2.00K | 0.00% | 00.0% | Unchanged |
| Column Capital Advisors, LLC | 51 | $2.00K | 0.00% | 00.0% | Unchanged |
| Proequities, Inc. | 38 | $2.00K | 0.00% | 00.0% | Unchanged |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 44 | $2.00K | 0.00% | +44 | New |
| Advisory Services Network, LLC | 55 | $2.00K | 0.00% | +55 | New |
| Strategic Blueprint, LLC | 52 | $2.00K | 0.00% | +52 | New |
| HM Payson & Co | 27 | $1.00K | 0.00% | 00.0% | Unchanged |
| Savior LLC | 33 | $1.00K | 0.00% | 00.0% | Unchanged |
| First Horizon Advisors, Inc. | 36 | $1.00K | 0.00% | +36 | New |
| JJJ Advisors Inc. | 20 | $1.00K | 0.00% | +20 | New |
| Arcadia Investment Advisors LLC | 14 | $572 | 0.00% | +14 | New |
| Meeder Asset Management Inc | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Ford Financial Group, LLC | 12 | $0 | 0.00% | +12 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 0 | $0 | 0.00% | −265,529−100.0% | Sold out |
| Parkwood LLC | 0 | $0 | 0.00% | −128,955−100.0% | Sold out |
| Navellier & Associates Inc | 0 | $0 | 0.00% | −101,518−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −81,058−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −78,500−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −78,338−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −73,015−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −55,672−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −39,100−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −23,611−100.0% | Sold out |
| CWM Advisors, LLC | 0 | $0 | 0.00% | −16,280−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −15,857−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −15,155−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −12,549−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Voya Financial Advisors, Inc. | 0 | $0 | 0.00% | −10,242−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | – | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −8,595−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −6,854−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −6,836−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −6,167−100.0% | Sold out |
| Nkcfo LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −878−100.0% | Sold out |
| Ameritas Investment Company, LLC | 0 | $0 | 0.00% | −658−100.0% | Sold out |
| D'Orazio & Associates, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −446−100.0% | Sold out |
| Eudaimonia Partners, LLC | 0 | $0 | 0.00% | −417−100.0% | Sold out |
| Carroll Financial Associates, Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −210−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Lenox Wealth Advisors, LLC | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −65−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| WealthShield Partners, LLC | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Glen Eagle Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Stuart Chaussee & Associates, Inc. | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Waddell & Reed Financial Inc | – | – | – | – | Not filed |